The Advantages of NaDCC for Surface Disinfection

Pathogens: Unseen, Unwelcome Holiday Guests

Candida auris: Understanding the Alarming Rise in Death Rates

Practical Approach to Sustainability

NYU Langone study confirms the efficacy of Kersia NaDCC chemistry

Rare Sudan Ebolavirus Outbreak

Sepsis affects 1.7 Million People Yearly in US

POLIOVIRUS

World Hepatitis Day 2022 – Virus Update

The risk of Healthcare Associated Infection in pediatric treatment units

MONKEYPOX OUTBREAK

Severe Acute Viral Hepatitis in Children

Do Your Disinfecting Protocols Cover all the Bases?

BIOFILM: THE INFECTION THREAT MANY HAVE NEVER HEARD OF

EPA approve use of Kersia Disinfectant Tablets with Electrostatic Sprayers

Continuously Active Disinfectants: Addressing Challenges of Surface Contamination

NaDCC effervescent tablets show continuous, sustained residual efficacy against C.diff

Candida auris – An Unusual Yeast Causing Serious Infection

Over the past number of years discussion surrounding Candida auris has continued to increase. This pathogen is regularly discussed by the media and governmental bodies

Hands can transfer biofilm, new research finds

Chowdhary et al. conducted a study investigating the role of healthcare worker’s hands in the transfer and spread of dry surface biofilm1. Dry surface biofilm has previously been found to be prevalent in healthcare environments and harbours multidrug resistant organisms2,3.

NaDCC at the forefront of the COVID-19 fight

Since the beginning of COVID-19 NaDCC tablets have been at the forefront of the fight.